187 related articles for article (PubMed ID: 35471813)
1. Implantation of transjugular intrahepatic portosystemic shunt (TIPS): indication and patient selection.
Bettinger D; Thimme R; Schultheiß M
Curr Opin Gastroenterol; 2022 May; 38(3):221-229. PubMed ID: 35471813
[TBL] [Abstract][Full Text] [Related]
2. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
3. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
Strunk H; Marinova M
Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
[TBL] [Abstract][Full Text] [Related]
4. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
[No Abstract] [Full Text] [Related]
6. The transjugular intrahepatic portosystemic shunt: an update.
Fidelman N; Kwan SW; LaBerge JM; Gordon RL; Ring EJ; Kerlan RK
AJR Am J Roentgenol; 2012 Oct; 199(4):746-55. PubMed ID: 22997364
[TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
Siramolpiwat S
World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
[TBL] [Abstract][Full Text] [Related]
8. Evolving Indications for Tips.
Smith M; Durham J
Tech Vasc Interv Radiol; 2016 Mar; 19(1):36-41. PubMed ID: 26997087
[TBL] [Abstract][Full Text] [Related]
9. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
10. The use and misuse of transjugular intrahepatic portasystemic shunts.
Sanyal AJ
Curr Gastroenterol Rep; 2000 Feb; 2(1):61-71. PubMed ID: 10981005
[TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunt for recompensating decompensated cirrhosis?
Karagiannakis DS
World J Gastroenterol; 2024 May; 30(20):2621-2623. PubMed ID: 38855160
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.
Horhat A; Bureau C; Thabut D; Rudler M
United European Gastroenterol J; 2021 Mar; 9(2):203-208. PubMed ID: 32819214
[TBL] [Abstract][Full Text] [Related]
13. Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.
Parker R
Clin Liver Dis; 2014 May; 18(2):319-34. PubMed ID: 24679497
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
[TBL] [Abstract][Full Text] [Related]
15. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
[TBL] [Abstract][Full Text] [Related]
17. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
18. Reduction in portal venous pressure by transjugular intrahepatic portosystemic shunt for treatment of hemorrhagic stomal varices.
Deipolyi AR; Kalva SP; Oklu R; Walker TG; Wicky S; Ganguli S
AJR Am J Roentgenol; 2014 Sep; 203(3):668-73. PubMed ID: 25148174
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of portal hypertension with transjugular intrahepatic portosystemic shunt: guidelines for referring suitable patients].
Astrup LB; Clemmesen JO; Frevert SC; Larsen FS; Nielsen DT; Schlichting P; Vilstrup H
Ugeskr Laeger; 2007 Aug; 169(34):2758-61. PubMed ID: 17878010
[TBL] [Abstract][Full Text] [Related]
20. The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls.
Lee HL; Lee SW
Clin Mol Hepatol; 2022 Apr; 28(2):121-134. PubMed ID: 34571587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
